Target intelligence / Profile preview

Aquaglyceroporin

Molecular classification
Transporter, Channel protein, Membrane Intrinsic Protein (MIP) superfamily
01

Overview

Aquaglyceroporins are a subfamily of membrane channel proteins within the Membrane Intrinsic Proteins (MIP) superfamily that conduct water, glycerol, and a range of small, uncharged solutes across biological membranes. Unlike "orthodox" aquaporins, which are strictly selective for water, aquaglyceroporins (including human AQP3, AQP7, AQP9, and AQP10) possess wider and more hydrophobic pores allowing facilitated diffusion of glycerol, urea, arsenic compounds, and other small molecules alongside water[2][4][5][8]. These proteins assemble as homotetramers, with each monomer forming its own pore. Aquaglyceroporins are broadly expressed, most notably in adipose tissue, liver, kidney, testis, and in some pathogens. They are essential for glycerol metabolism, energy homeostasis, and have pathophysiological roles in metabolic diseases (such as obesity and diabetes), cancer, and arsenic toxicity. They are regarded as potential drug targets for the modulation of metabolic processes and as uptake routes for therapeutic agents in infectious organisms. No approved drugs directly target aquaglyceroporins in humans, but pharmacological modulators are under investigation[2][5][8].

Other names
Aquaglyceroporin channelAquaglyceroporin familyGlycerol facilitator (GlpF in bacteria)AQP3AQP7AQP9AQP10 (human paralogs)
02

Mechanism of action

Channel inhibition (block of glycerol or water permeability); Substrate analog competition; Exploitation as uptake route for cytotoxic agents or antimicrobials (in some pathogens)

03

Biological functions

Glycerol transportWater transportSmall solute transport (e.g., urea, arsenic, monocarboxylates, polyols)Metabolite balanceEnergy homeostasis
04

Disease associations

Metabolic disease (including obesity and diabetes)CancerInfectionCardiovascular diseaseOther (arsenic toxicity)
05

Safety considerations

Broad physiological roles and tissue expression may lead to significant on-target toxicity including disturbance in water balance, adipose/glycerol metabolism, and cellular osmoregulation[5][2].Development of isoform- or tissue-specific inhibitors remains a challenge to limit side effects.
06

Interacting drugs

At present, there are no clinically approved drugs directly targeting aquaglyceroporins; however, small molecule inhibitors and modulators have been identified in preclinical studies[2]. Some anti-infective drugs utilize aquaglyceroporins for cell entry (e.g., antimony-based drugs in Leishmania via AQP9 orthologs)[8].
07

Biomarkers

Glycerol levels (in plasma/urine as indirect indication)AQP7 expression in adipose tissue (linked to obesity/metabolic diseases)[5][7][9]

Beyond the preview

Go deeper on Aquaglyceroporin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaglyceroporin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call